Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG 3350 with ascorbate versus PEG4000 for bowel preparation in older adults
ChiCTR2600132827Phase 4Not yet recruiting
- Sponsor
- Guangxi Medical University Second Affiliated Hospital
- Start
- Jul 2026
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of polyethylene glycol 3350, ascorbic acid and macrogol 4000 (2 arms), sponsored by Guangxi Medical University Second Affiliated Hospital. Primary endpoint: Bowel preparation adequacy rate. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
polyethylene glycol 3350ascorbic acidmacrogol 4000
Beyond the preview
Go deeper on ChiCTR2600132827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600132827.